Olema Pharmaceuticals, Inc. (OLMA) Earnings History
Annual and quarterly earnings data from 2018 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export OLMA earnings history in CSV or JSON format
Free sign-in required to download data
Olema Pharmaceuticals, Inc. (OLMA) Earnings Overview
As of March 3, 2026, Olema Pharmaceuticals, Inc. (OLMA) reported trailing twelve-month net income of -$150M, reflecting -0.0% year-over-year growth. The company earned $-1.75 per diluted share over the past four quarters.
Looking at the long-term picture, OLMA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2018.
Olema Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to industry peers including RVMD (-$1.13B net income), INCY ($1.29B net income, 0.3% margin), GMAB ($6.57B net income, 0.4% margin), OLMA has comparable earnings metrics. Compare OLMA vs RVMD →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$129M | -34.0% | -$142M | $-2.20 | - | - |
| 2023 | -$97M | +7.8% | -$105M | $-2.14 | - | - |
| 2022 | -$105M | -47.4% | -$107M | $-2.62 | - | - |
| 2021 | -$71M | -221.4% | -$71M | $-1.79 | - | - |
| 2020 | -$22M | -412.5% | -$22M | $-0.58 | - | - |
| 2019 | -$4M | -96.4% | -$4M | $-0.11 | - | - |
| 2018 | -$2M | - | -$2M | $-0.16 | - | - |
See OLMA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OLMA Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare OLMA vs AGIO
See how OLMA stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is OLMA growing earnings?
OLMA TTM EPS: $-1.75. Net income: $-150M. Earnings growth: -0.0%.
What are OLMA's profit margins?
Olema Pharmaceuticals, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are OLMA's earnings?
OLMA earnings data spans 2018-2024. The current earnings trend is -0.0% YoY. Historical data enables comparison across business cycles.